Authors: Abrams P;Mattiasson A;Lose GR;Robertson GL;. Title: The role of desmopressin in the treatment of adult nocturia. [Review] [15 refs]. Journal Name: BJU International. Year: 2002 Dec | Review of 2 primary studies; Lose 2003 which is included; and an identical study in men. |
Authors: Abrams P;Swift S;. Title: Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis. Journal Name: European Urology. Year: 2005 Sep | Studies included in the analysis already included in the guideline. |
Authors: Ahlstrom K;Sandahl B;Sjoberg B;Ulmsten U;Stormby N;Lindskog M;. Title: Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence. Journal Name: Gynecologic and Obstetric Investigation. Year: 1990 | The study aims to establish whether adding phenylpropanolamine (PPA) to oestrogen affects outcomes, which is not a question that's relevant to the guideline because PPA is not used nor available in the UK. |
Authors: Altan-Yaycioglu R;Yaycioglu O;Aydin Akova Y.;Guvel S;Ozkardes H;. Title: Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial. Journal Name: British Journal of Clinical Pharmacology. Year: 2005 May | Study investigates visual effects after 4 weeks treatment, more in relation to mechanism of ocular side effects than effectiveness of drug treatment. |
Authors: Blom MW;Sommers DK;. Title: The effects of an estradiol transdermal therapeutic system, alone and in combination with naproxen, on urge incontinence in elderly women: A pilot study. Journal Name: Current Therapeutic Research Clinical and Experimental. Year: 1995 | Cross-over RCT (n=16) with 3 arms (estradiol patch with or without naproxen, and placebo), but not clear of total duration of study. Lack of information about characteristics of patients other than they had ‘established detrusor instability’. Results impossible to interpret - mean values of maximum bladder capacity and volume at first urge to void reported (unclear whether this was at endpoint), but no baseline data against which to compare the results. Bladder diaries kept, ‘significant improvements’ reported but no numerical data. |
Authors: Blonski J;. Title: Is tolterodine (Detrol) or oxybutynin (Ditropan) the best for treatment of urge urinary incontinence?. Journal Name: Journal of Family Practice. Year: 2001 Dec | Not the primary report of the meta-analysis (Harvey 2001). |
Authors: Cardozo LD;Wise BG;Benness CJ;. Title: Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal women - A double-blind placebo-controlled study. Journal Name: Journal of Obstetrics and Gynaecology. Year: 2001 | RCT of 104 women; no useable data (no numerical data reported for any results). |
Authors: Chaliha C;Halaska M;Stanton SL;. Title: Trospium chloride for the treatment of detrusor instability: a placebo-controlled dose-finding study. Journal Name: British Journal of Obstetrics and Gynaecology. Year: 1998 | Abstract. |
Authors: Coombes GM;Millard RJ;. Title: Urinary urge incontinence: randomised crossover trials of penthienate versus placebo and propantheline. Journal Name: Medical Journal of Australia. Year: 1996 Nov 4 | 2 cross-over RCTs combined in 1 report; penthienate vs. placebo (n=20) and propantheline vs. penthienate (n=23).{22879} Penthienate is an antimuscarinic drug, not used in the UK. |
Authors: Chapple C;Steers W;Norton P;Millard R;Kralidis G;Glavind K;Abrams P;. Title: A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder. Journal Name: BJU International. Year: 2005 | Source of original trial data not referenced. |
Authors: Chapple CR;Abrams P;. Title: Comparison of darifenacin and oxybutynin in patients with overactive bladder: assessment of ambulatory urodynamics and impact on salivary flow. Journal Name: European Urology. Year: 2005 Jul | 7 days treatment only; main outcome urodynamic parameters. Does not address effectiveness for UI/OAB. |
Authors: Dmochowski RR;Nitti V;Staskin D;Luber K;Appell R;Davila GW;. Title: Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials. Journal Name: World Journal of Urology. Year: 2005 Sep | Pooled analysis of 2 RCTs that are already included. |
Authors: Ek A;Andersson KE;Gullberg B;Ulmsten U;. Title: Effects of oestradiol and combined norephedrin and oestradiol treatment on female stress incontinence. Journal Name: Zentralblatt fur Gynakologie. Year: 1980 | The study aims to establish whether treatment with norephedrin (phenylpropanolamine) plus estradiol is better than estradiol alone in 13 women with stress UI. This is not a question that is relevant to the guideline because we are not looking at PPA, as it is neither used nor available in the UK. |
Authors: Fantl JA;Cardozo L;McClish DK;. Title: Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Journal Name: Obstetrics and Gynecology. Year: 1994 | Systematic review outdated by several subsequent publications. Use as source of references. |
Authors: Foote J;Glavind K;Kralidis G;Wyndaele J;. Title: Treatment of overactive bladder in the older patient: Pooled analysis of three phase III studies of darifenacin, an M3 selective receptor antagonist. Journal Name: European Urology. Year: 2005 | Source of original trial data not referenced. |
Authors: Freeman R;Hill S;Millard R;Slack M;Sutherst J;Tolterodine Study Group.;. Title: Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine. Journal Name: Obstetrics and Gynecology. Year: 2003 Sep | Secondary analysis of RCT (van Kerrebroeck, ref ID: 22836; included). |
Authors: Garcia JMO, Agullo EM, Sugranes JC, Cruz JFJ. Title: A comparison of trospium chloride and oxybutynin in the treatment of hyperacive bladder; a randomized double-blind study. Journal Name: Urod A. Year: 1997 | 72% of study population (n=67) had neurogenic bladder which is outside the guideline scope. Assessment of urodynamic findings only - no baseline symptom data, and no outcomes related to symptoms. |
Authors: Gleason DM;Susset J;White C;Munoz DR;Sand PK;. Title: Evaluation of a new once- daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group. Journal Name: Urology. Year: 1999 Sep | Case series of patients transferred from immediate-release oxybutynin to a controlled-release formulation, or taking oxybutynin (CR) for the first time. No control group. |
Authors: Gruneberger A;. Title: Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride. Journal Name: British Journal of Obstetrics and Gynaecology. Year: 1984 Mar | Comparison group is clenbuterol which is not used in the UK. |
Authors: Henalla SM;Hutchins CJ;Robinson P;MacVicar J;. Title: Non-operative methods in the treatment of female genuine stress incontinence of urine. Journal Name: Journal of Obstetrics and Gynaecology. Year: 1989 | Abstract publication, not subsequently published in full. |
Authors: Hilton P, Tweddell AL, Mayne C. Title: Oral and intravaginal estrogens alone and in combination with alpha-adrenergic stimulation in genuine stress incontinence. Journal Name: Int Urogynaecology. Year: 1990 | RCT with 6 tx arms, including 2 of oestrogen only and placebo, and another 3 arms involving phenylpropanolamine alone or in combination with oestrogen (n=10 per grp). Only data for oestrogen alone or placebo of relevance to the guideline, but numerical data for symptom outcomes not reported (only in graphs); complete urodynamic data reported. Other RCTs in the guideline included have compared oestrogen with placebo in the same population over longer periods. |
Authors: Homma Y;Kawabe K;. Title: Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial. Journal Name: World Journal of Urology. Year: 2004 Oct | Paper reports results for the Japanese patients included in the Homma 2003 study; study excluded due to duplication of data. |
Authors: Junemann KP;Halaska M;Rittstein T;Murtz G;Schnabel F;Brunjes R;Nurkiewicz W;. Title: Propiverine versus tolterodine: efficacy and tolerability in patients with overactive bladder. Journal Name: European Urology. Year: 2005 Sep | 4-week study that focused on cystometric capacity, therefore does not address effectiveness. |
Authors: Kinn AC;Lindskog M;. Title: Estrogens and phenylpropanolamine in combination for stress urinary incontinence in postmenopausal women. Journal Name: Urology. Year: 1988 Sep | The study aims to establish whether treatment with phenylpropanolamine plus estriol is better than estriol alone in 36 women with stress UI. This is not a question that is relevant to the guideline because we are not looking at PPA, as it is neither used nor available in the UK. |
Authors: Kuo H;. Title: Efficacy of desmopressin in treatment of refractory nocturia in patients older than 65 years. Journal Name: Urology. Year: 2002 | Case series of desmopressin use in 30 patients (5 women). Evidence of higher level available to address this question. |
Authors: Larsson G;Hallen B;Nilvebrant L;. Title: Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data. Journal Name: Urology. Year: 1999 May | Pooled analysis from 4 placebo-controlled dose-ranging RCTs that evaluated tolterodine. 2 of the studies included patients with detrusor hyperreflexia which is outside the guideline scope. Relevant studies included were considered separately. |
Authors: Milani R;Scalambrino S;Carrera S;Pezzoli P;Ruffmann R;. Title: Flavoxate hydrochloride for urinary urgency after pelvic radiotherapy: comparison of 600 mg versus 1200 mg daily dosages. Journal Name: Journal of International Medical Research. Year: 1988 Jan | Case series of women treated with flavoxate for urgency after pelvic radiotherapy. |
Authors: Millard RJ;Halaska M;. Title: Efficacy of solifenacin in patients with severe symptoms of overactive bladder: A pooled analysis. Journal Name: Current Medical Research and Opinion. Year: 2006 | Source of data for one of the trials was 'data on file'. |
Authors: Moore KH;Hay DM;Imrie AE;Watson A;Goldstein M;. Title: Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability. Journal Name: British Journal of Urology. Year: 1990 Nov | Small cross-over study of oxybutynin and placebo, of short duration. Other more robust and recent studies that address the same question are included. |
Authors: Radomski SB;Caley B;Reiz JL;Miceli PC;Harsanyi Z;Darke AC;. Title: Preliminary evaluation of a new controlled-release oxybutynin in urinary incontinence. Journal Name: Current Medical Research and Opinion. Year: 2004 | Pilot study of immediate/controlled release oxybutynin (2wks/2wks washout/4 wks) in 12 patients who acted as their own controls. Other more robust studies included. |
Authors: Riva D;Casolati E;. Title: Oxybutynin chloride in the treatment of female idiopathic bladder instability. Results from double blind treatment. Journal Name: Clinical and Experimental Obstetrics and Gynecology. Year: 1984 | Small cross-over study of oxybutynin and placebo, of short duration. Other more robust and recent studies that address the same question are included. |
Authors: Robinson JM;Brocklehurst JC;. Title: Emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence associated with detrusor instability in elderly women. Journal Name: British Journal of Urology. Year: 1983 Aug | Emepronium plus flavoxate compared with placebo; emepronium not used in the UK. |
Authors: Rud T;. Title: The effects of estrogens and gestagens on the urethral pressure profile in urinary continent and stress incontinent women. Journal Name: Acta Obstetricia et Gynecologica Scandinavica. Year: 1980 | Does not address effectiveness; UPP and urethral length measured after 3 wks tx with estradiol or estriol, or after a single 1 gram dose of progesterone. |
Authors: Salvatore S;Khullar V;Cardozo L;Milani R;Athanasiou S;Kelleher C;. Title: Long-term prospective randomized study comparing two different regimens of oxybutynin as a treatment for detrusor overactivity. Journal Name: European Journal of Obstetrics, Gynecology, and Reproductive Biology. Year: | Comparison of 2 different starting dose regimens of oxybutynin (2.5mg bd or 5mg at night). No other control group. |
Authors: Sartori MGF;Baracat EC;Girao MJBC;Goncalves WJ;Sartori JP;Rodrigues dL;. Title: Menopausal genuine stress urinary incontinence treated with conjugated estrogens plus progestogens. Journal Name: International Journal of Gynecology and Obstetrics. Year: 1995 | Case series. |
Authors: Sherman AM;Shumaker SA;Kancler C;Zheng B;Reboussin DM;Legault C;Herrington DM;. Title: Baseline health-related quality of life in postmenopausal women with coronary heart disease: the Estrogen Replacement and Atherosclerosis (ERA) Trial. Journal Name: Journal of Women's Health. Year: 2003 | Does not address effectiveness of oestrogens for UI. This report analyses baseline health-related QOL data, including UI, from a study evaluating the effects of oestrogen with or without progestogen on coronary atherosclerosis. |
Authors: Stanton SL;. Title: A comparison of emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence. Journal Name: Journal of Urology. Year: 1973 | Comparison of emepronium and flavoxate. Emepronium not used in the UK. |
Authors: Sussman D;Garely A;. Title: Treatment of overactive bladder with once-daily extended-release tolterodine or oxybutynin: the antimuscarinic clinical effectiveness trial (ACET).[see comment]. Journal Name: Current Medical Research and Opinion. Year: 2002 | Reported to be a comparison of 2 doses each of SR tolterodine and SR oxybutynin. It was effectively 2 separate trials, with the 340 centres that were involved in the study; each evaluating only 1 of the study drugs. However results are analysed as though they were comparisons of the different drugs, with little useful information about differences between the doses of different drugs. Endpoints were patient perception of benefit and dry mouth. ITT analysis done for those randomised and received ≥ 1 dose of study medication & had 1 efficacy assessment. No explanation for missing data. |
Authors: Tapp AJ;Cardozo LD;Versi E;Cooper D;. Title: The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study.[see comment]. Journal Name: British Journal of Obstetrics and Gynaecology. Year: 1990 Jun | Small cross-over study of oxybutynin and placebo, of short duration. Other more robust and recent studies that address the same question are included. |
Authors: Weatherall M;. Title: The risk of hyponatremia in older adults using desmopressin for nocturia: a systematic review and meta-analysis. [Review] [37 refs]. Journal Name: Neurourology and Urodynamics. Year: 2004 | This review pooled the incidence of hyponatraemia in studies where desmopressin was used to treat nocturia. Seven studies were included (including the Asplund RCT and Asplund dose-titration study, and Kuo 2002 [excluded]); 3 studies included only men, and 5 included men and women. No single definition of hyponatraemia was used in the studies included, nor a definition given in the review. Studies of any duration were included (3 days to 3 months). The pooled estimate reported was 7.6% (95% CI 3.1, 15.1). However, the review had unclear methods, and conflicting information about type of studies included (said controlled only, but case series included). The appropriateness of pooling the results is questionable as the largest study included (n=224 [56%], only men) reported a much higher incidence (21.9%) than the other studies (3.3–8.7%), and also because the lack of definition of hyponatraemia and variation in study durations makes it difficult to put the pooled estimate into any context. |
Authors: Wein AJ;. Title: Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Journal Name: Journal of Urology. Year: 2005 Jun | Commentary on study included in guideline (ref ID 22918, Khullar 2004). |
Authors: Weisberg E;Ayton R;Darling G;Farrell E;Murkies A;O'Neill S;Kirkegard Y;Fraser IS;. Title: Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Journal Name: Climacteric. Year: 2005 | Although % reporting urgency and frequency at 48 weeks is given, neither the change from baseline, nor the baseline prevalence of these symptoms is reported therefore there are no useable data in this study in relation to UI. |
Authors: Whitehead JA;. Title: Urinary incontinence in the aged. Propantheline bromide as an adjunct to treatment. Journal Name: Geriatrics. Year: 1967 Jan | A study evaluating 2 weeks propantheline and placebo tx in 20 female cognitively impaired elderly inpatients with UI. Pts were also undergoing habit training, but no details of this given. Lack of other details makes it difficult to decipher what actually happened in the study. |
Authors: Zeegers A;Kiesswetter H;Kramer A;Jonas U;. Title: Conservative therapy of frequency, urgency and urge incontinence: a double blind clinical trial of flavoxate hydrochloride, oxybutinin chloride, emepronium bromide and placebo. Journal Name: World Journal of Urology. Year: 1987 | Several limitations; 60 randomised, only 41 analysed (completers) - 8 of 19 withdrawlas were due to emepronium side effects; study conducted at 2 centres and significant differences in baseline symptoms between the 2, with more in 1 having DO therefore results presented for the 2 centres separately. |
Authors: Zinner N;Tuttle J;Marks L;. Title: Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder. Journal Name: World Journal of Urology. Year: 2005 Sep | 2 weeks treatment only therefore insufficient duration to address effectiveness. |
Authors: Zorzitto ML;Jewett MAS;Fernie GR;Holliday PJ;Bartlett S;. Title: Effectiveness of Propantheline bromide in the treatment of geriatric patients with detrusor instability. Journal Name: Neurourology and Urodynamics. Year: 1986 | Majority of the population of 43 have neurogenic bladder, outside the guideline scope. |
Authors: Zorzitto ML;Holliday PJ;Jewett MA;Herschorn S;Fernie GR;. Title: Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled study.[see comment]. [Review] [28 refs]. Journal Name: Age and Ageing. Year: 1989 May | Small cross-over study of oxybutynin and placebo, of short duration. Other more robust and recent studies that address the same question are included. |
Authors: Zullo MA;Plotti F;Calcagno M;Palaia I;Muzii L;Manci N;Angioli R;Panici PB;. Title: Vaginal estrogen therapy and overactive bladder symptoms in postmenopausal patients after a tension-free vaginal tape procedure: a randomized clinical trial. Journal Name: Menopause. Year: 2005 Jul | The question considered is whether oestrogen reduces the incidence of OAB as a complication of TVT surgery, and not the effectiveness of the procedure per se. |